Glioblastoma Multiforme (GBM) Treatment Market Outlook, Key Players, Massive Growth, Demand, Top Trends And Forecast 2032 - Merck & Co Inc., F. Hoffmann-La Roche AG, Amgen Inc., Pfizer Inc

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

Glioblastoma Multiforme (GBM) Treatment Market Size, Growth Rate, And Forecast

The global glioblastoma multiforme (GBM) treatment market is expected to grow from $2.04 billion in 2022 to $2.26 billion in 2023 at a compound annual growth rate (CAGR) of 10.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The glioblastoma multiforme (GBM) treatment market is expected to grow to $3.26 billion in 2027 at a CAGR of 9.7%.

Request A Free Sample Of The Glioblastoma Multiforme (GBM) Treatment Market Report Here ---
https://www.thebusinessresearchcompany.com/sample.aspx?id=8803&type=smp

Glioblastoma Multiforme (GBM) Treatment Market Drivers

The increasing prevalence of brain disorders is expected to propel the growth of the glioblastoma multiforme (GBM) treatment market going forward. Brain disorders refer to abnormal functioning of the brain as well as the nerves found throughout the human body and the spinal cord. The increasing prevalence of brain disorders such as glioblastoma multiforme (GBM) is due to various contributing factors such as the aging population, compromised immune systems, overdiagnosis, ionizing radiation, air pollution, and others which creates the need for the treatment of brain disorders to improve well-being. For instance, according to the report published by Globocan, a US-based international agency for providing global cancer statistics, approximately 308,102 cancer cases were detected for the brain and central nervous system, and 251,329 deaths in the year 2020 globally. Additionally, according to a report published by the American Cancer Society, a US-based voluntary health organization dedicated to eliminating cancer, in 2022, it is estimated around 25,050 malignant tumors of the brain or spinal cord cancer cases will be diagnosed in the US. Therefore, the increasing prevalence of brain disorders is driving the growth of the glioblastoma multiforme (GBM) treatment market.

Learn More On The Glioblastoma Multiforme (GBM) Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/report/glioblastoma-multiforme-gbm-treatment-global-market-report

Glioblastoma Multiforme (GBM) Treatment Market Segments

• By Treatment: Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy, Tumor Treating Field (TTF) Therapy, Immunotherapy

• By Drug Class: Temozolomide, Bevacizumab, Lomustine, Carmustine Wafers, Other Drug Classes

• By Route of Administration: Oral, Parenteral, Other Route Of Administrations

• By End-Use: Hospitals, Clinics, Ambulatory Surgical Centers

• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the glioblastoma multiforme (GBM) treatment market.

Check Out Buying Options For The Glioblastoma Multiforme (GBM) Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8803

Glioblastoma Multiforme (GBM) Treatment Market Key Players
Major competitors in the glioblastoma multiforme (GBM) treatment market include Merck & Co Inc., F. Hoffmann-La Roche AG, Amgen Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Limited, Arbor Pharmaceuticals LLC, Amneal Pharmaceuticals Inc., Karyopharm Therapeutics, Sumitomo Pharma Oncology.

The Business Research Company's "Global Glioblastoma Multiforme (GBM) Treatment Market Report 2023" is a comprehensive report of the market, covering over 60 geographies and high level market segmentation per geography. The section on regional and country breakdowns examines the market in each geography as well as market size by region and country. Furthermore, it evaluates the market's historical and projected growth and identifies significant trends and strategies that businesses can use to expand their operations.

The Table Of Content For The Glioblastoma Multiforme (GBM) Treatment Market Include:
1. Executive Summary
2. Glioblastoma Multiforme (GBM) Treatment Market Characteristics
3. Glioblastoma Multiforme (GBM) Treatment Market Trends And Strategies
4. Glioblastoma Multiforme (GBM) Treatment Market - Macro Economic Scenario
5. Glioblastoma Multiforme (GBM) Treatment Market Size And Growth
………………
27. Glioblastoma Multiforme (GBM) Treatment Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Glioblastoma Multiforme (GBM) Treatment Market
29. Glioblastoma Multiforme (GBM) Treatment Market Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, seafood, seafood, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic.

This release was published on openPR.